Ozanimod

Ozanimod is a prescription drug used to treat relapsing-remitting multiple sclerosis (MS). It is an immunomodulator, meaning it works by modifying the body's immune response that contributes to MS. Ozanimod works to slow down the progression of the disease, prevent relapses, reduce the risk of disability, and improve overall quality of life for those living with MS. It has been shown to be well tolerated compared to injectable therapies and may reduce the frequency and severity of relapses. Ozanimod is taken orally once a day and may provide a more convenient treatment option for those living with MS.

← International Journal of Multiple Sclerosis and Related Disorders

Related Articles

1 journal(s) found

International Journal of Multiple Sclerosis and Related Disorders

ISSN: Coming Soon
Type: Open Access Journal
Editor: Derrick Robertson, University of South Florida, Morsani College of Medicine, Department of Neurology, MS Division.
The Journal of Sclerosis is an online, open-access, peer-reviewed journal which concentrates mainly on the field of sclerosis. JSC accepts all types of articles, including research, reviews, short communications, editorials, and case reports in all fields of sclerosis; also, it encourages researchers and academics to upgrade according to the